Publication: The TT genotype of the STAT4 rs7574865 polymorphism is associated with high disease activity and disability in patients with early arthritis
dc.contributor.author | Lamana, Amalia | |
dc.contributor.author | Balsa, Alejandro | |
dc.contributor.author | Rueda, Blanca | |
dc.contributor.author | Ortiz, Ana M | |
dc.contributor.author | Nuño, Laura | |
dc.contributor.author | Miranda-Carus, Maria Eugenia | |
dc.contributor.author | Gonzalez-Escribano, Maria F | |
dc.contributor.author | Lopez-Nevot, Miguel A | |
dc.contributor.author | Pascual-Salcedo, Dora | |
dc.contributor.author | Martin, Javier | |
dc.contributor.author | González-Álvaro, Isidoro | |
dc.contributor.authoraffiliation | [Lamana,A; Ortiz,AM; González-Álvaro,I] Rheumatology Service, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa, Madrid, Spain. [Balsa,A; Nuño,L; Miranda-Carus,ME] Rheumatology Service, Hospital Universitario La Paz, IdiPaz, Instituto de Investigación Sanitaria La Paz, Madrid, Spain. [Rueda,B] Departamento de Enfermería, Facultad de Ciencias de la Salud, Universidad de Granada, Granada, Spain. [Gonzalez-Escribano,MF] Immunology Service, Hospital Universitario Virgen del Rocio, Sevilla, Spain. [Lopez-Nevot,MA] Immunology Service, Hospital Universitario Virgen de las Nieves, Granada, Spain. [Pascual-Salcedo,D] Immunology Service, Hospital Universitario La Paz, IdiPaz, Instituto de Investigación Sanitaria La Paz, Madrid, Spain. [Martin,J] Instituto de Parasitología y Biomedicina Lopez Neyra, CSIC, Granada, Spain | es |
dc.contributor.funder | This work was partially supported by the RETICS (Redes Tematicas de Investigación Cooperativa, Cooperative Research Thematic Networks) Program, RD08/0075 (RIER) and FIS (Fondo de Investigación en Salud) Health Research Fund grant FIS 08/0754 to IG-A from Instituto de Salud Carlos III (ISCIII; www.isciii.es) and by grants from the European Innovative Medicines Initiative and BTCure Program (http://www.life-sciences-europe.com/organisation/btcure-project-imi-efpia-201103-innovative-medicines-initiative-2001-28657.html). The work of IG-A was in part supported by a Research Intensification Grant from the National Health Care System (Instituto Carlos III; www.isciii.es), Madrid, Spain. | |
dc.date.accessioned | 2013-12-04T13:58:16Z | |
dc.date.available | 2013-12-04T13:58:16Z | |
dc.date.issued | 2012-08-24 | |
dc.description | Journal Article; Research Support, Non-U.S. Gov't. The authors have read the journal’s policy and some authors have the following conflicts: Unrestricted research grants have been provided by Roche, UCB and Bristol-Myers Squibb to IG-A; and by Abbott Laboratories and Roche to LN. All these research projects have no relation with the present study. AB holds an advisory board membership with Pfizer and UCB. The following authors hold Honoraria for speaking: IG-A (Spanish Society of Rheumatology (SER), Rheumatology Society of Madrid (SORCOM), Roche, Abbott Laboratories and Bristol-Myers Squibb); AB (Roche, Schering-Plough, Wyeth, Abbott, BMS, Janssen and UCB); AMO (Spanish Society of Rheumatology (SER), Laboratorios Esteve, Abbott Laboratories and MSD); JM (Spanish Society of Rheumatology (SER)); and LN (Abbott Laboratories). The remaining authors have declared that no competing interests exist. There are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials, as detailed online on the guide for authors. | es |
dc.description.abstract | BACKGROUND The number of copies of the HLA-DRB1 shared epitope, and the minor alleles of the STAT4 rs7574865 and the PTPN22 rs2476601 polymorphisms have all been linked with an increased risk of developing rheumatoid arthritis. In the present study, we investigated the effects of these genetic variants on disease activity and disability in patients with early arthritis. METHODOLOGY AND RESULTS We studied 640 patients with early arthritis (76% women; median age, 52 years), recording disease-related variables every 6 months during a 2-year follow-up. HLA-DRB1 alleles were determined by PCR-SSO, while rs7574865 and rs2476601 were genotyped with the Taqman 5' allelic discrimination assay. Multivariate analysis was performed using generalized estimating equations for repeated measures. After adjusting for confounding variables such as gender, age and ACPA, the TT genotype of rs7574865 in STAT4 was associated with increased disease activity (DAS28) as compared with the GG genotype (β coefficient [95% confidence interval] = 0.42 [0.01-0.83], p = 0.044). Conversely, the presence of the T allele of rs2476601 in PTPN22 was associated with diminished disease activity during follow-up in a dose-dependent manner (CT genotype = -0.27 [-0.56- -0.01], p = 0.042; TT genotype = -0.68 [-1.64- -0.27], p = 0.162). After adjustment for gender, age and disease activity, homozygosity for the T allele of rs7574865 in STAT4 was associated with greater disability as compared with the GG genotype. CONCLUSIONS Our data suggest that patients with early arthritis who are homozygous for the T allele of rs7574865 in STAT4 may develop a more severe form of the disease with increased disease activity and disability. | es |
dc.description.version | Yes | es |
dc.identifier.citation | Lamana A, Balsa A, Rueda B, Ortiz AM, Nuño L, Miranda-Carus ME, et al. The TT genotype of the STAT4 rs7574865 polymorphism is associated with high disease activity and disability in patients with early arthritis. PLoS ONE. 2012; 7(8):e43661 | es |
dc.identifier.doi | 10.1371/journal.pone.0043661 | |
dc.identifier.essn | 1932-6203 | |
dc.identifier.pmc | PMC3427144 | |
dc.identifier.pmid | 22937072 | |
dc.identifier.uri | http://hdl.handle.net/10668/1408 | |
dc.journal.title | PloS one | |
dc.language.iso | en | |
dc.publisher | Public Library of Science | es |
dc.relation.publisherversion | http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0043661 | es |
dc.rights.accessRights | open access | |
dc.subject | STAT4 Transcription Factor | es |
dc.subject | PTPN22 protein, human | es |
dc.subject | Protein Tyrosine Phosphatase, Non-Receptor Type 22 | es |
dc.subject | HLA-DRB1 Chains | es |
dc.subject | Anciano | es |
dc.subject | Alelos | es |
dc.subject | Artritis | es |
dc.subject | Evaluación de la Discapacidad | es |
dc.subject | Predisposición Genética a la Enfermedad | es |
dc.subject | Genotipo | es |
dc.subject | Mediana Edad | es |
dc.subject | Polimorfismo de Nucleótido Simple | es |
dc.subject | Factor de Transcripción STAT4 | es |
dc.subject | Índice de Severidad de la Enfermedad | es |
dc.subject | Adulto | es |
dc.subject.mesh | Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Aged | es |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Structures::Genome::Genome Components::Genes::Alleles | es |
dc.subject.mesh | Medical Subject Headings::Diseases::Musculoskeletal Diseases::Joint Diseases::Arthritis | es |
dc.subject.mesh | Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Disability Evaluation | es |
dc.subject.mesh | Medical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Disease Susceptibility::Genetic Predisposition to Disease | es |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genotype | es |
dc.subject.mesh | Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans | es |
dc.subject.mesh | Medical Subject Headings::Check Tags::Male | es |
dc.subject.mesh | Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Middle Aged | es |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Variation::Polymorphism, Genetic::Polymorphism, Single Nucleotide | es |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Peptides::Intracellular Signaling Peptides and Proteins::Adaptor Proteins, Signal Transducing::STAT Transcription Factors::STAT4 Transcription Factor | es |
dc.subject.mesh | Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Health Surveys::Health Status Indicators::Severity of Illness Index | es |
dc.subject.mesh | Medical Subject Headings::Named Groups::Persons::Age Groups::Adult | es |
dc.subject.mesh | Medical Subject Headings::Check Tags::Female | es |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Biological Factors::Antigens::Antigens, Surface::Histocompatibility Antigens::HLA Antigens::HLA-D Antigens::HLA-DR Antigens::HLA-DR beta-Chains::HLA-DRB1 Chains | es |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Hydrolases::Esterases::Phosphoric Monoester Hydrolases::Protein Tyrosine Phosphatases::Protein Tyrosine Phosphatases, Non-Receptor::Protein Tyrosine Phosphatase, Non-Receptor Type 22 | es |
dc.title | The TT genotype of the STAT4 rs7574865 polymorphism is associated with high disease activity and disability in patients with early arthritis | es |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Lamana_TheTTGenotype.pdf
- Size:
- 419.03 KB
- Format:
- Adobe Portable Document Format
- Description: